[HTML][HTML] Receptor tyrosine kinases in osteosarcoma treatment: which is the key target?

Z Tian, X Niu, W Yao - Frontiers in Oncology, 2020 - frontiersin.org
Recent clinical trials have shown several multi-target tyrosine kinase inhibitors (TKIs) to be
effective in the treatment of osteosarcoma. However, these TKIs have a number of targets …

Receptor Tyrosine Kinases in Osteosarcoma Treatment: Which Is the Key Target?

Z Tian, X Niu, W Yao - Frontiers in Oncology, 2020 - europepmc.org
Recent clinical trials have shown several multi-target tyrosine kinase inhibitors (TKIs) to be
effective in the treatment of osteosarcoma. However, these TKIs have a number of targets …

[HTML][HTML] Receptor Tyrosine Kinases in Osteosarcoma Treatment: Which Is the Key Target?

Z Tian, X Niu, W Yao - Frontiers in Oncology, 2020 - ncbi.nlm.nih.gov
Recent clinical trials have shown several multi-target tyrosine kinase inhibitors (TKIs) to be
effective in the treatment of osteosarcoma. However, these TKIs have a number of targets …

Receptor Tyrosine Kinases in Osteosarcoma Treatment: Which Is the Key Target?

Z Tian, X Niu, W Yao - Frontiers in oncology, 2020 - pubmed.ncbi.nlm.nih.gov
Recent clinical trials have shown several multi-target tyrosine kinase inhibitors (TKIs) to be
effective in the treatment of osteosarcoma. However, these TKIs have a number of targets …

[引用][C] Receptor Tyrosine Kinases in Osteosarcoma Treatment: Which Is the Key Target?

Z Tian, X Niu, W Yao - Frontiers in Oncology, 2020 - cir.nii.ac.jp
Receptor Tyrosine Kinases in Osteosarcoma Treatment: Which Is the Key Target? | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …